Our Pharma Partnering team is passionate about creating value for everyone involved - people living with serious diseases, our partners and the company as a whole.
More than 40 years ago, Genentech was born out of a partnership – a collaboration between our co-founder Herb Boyer and his research colleague, Stanley Cohen, which led to the scientific breakthrough of engineering recombinant human DNA into bacteria. That collaboration laid the foundation for Genentech and the entire biotechnology industry.
We are committed to developing innovative treatments for people with difficult-to-treat diseases, but we cannot accomplish this on our own. By partnering with the brightest minds in science and healthcare, we will have the potential to discover and develop ground-breaking treatments that can change people’s lives.
Working with us means working respectfully eye-to-eye with peers who share a passion for changing patients' lives through pioneering science and technology.
Artificial intelligence is boosting the drug discovery and development process.
Joining Forces in Neuroscience
Learn how we are transforming neuroscience research through partnerships.
Hear from our partners how joining forces can accelerate the discovery and development of breakthroughs.